tiprankstipranks
Tenet Healthcare (THC)
NYSE:THC
US Market
Want to see THC full AI Analyst Report?

Tenet Healthcare (THC) Earnings Dates, Call Summary & Reports

979 Followers

Earnings Data

Report Date
Jul 16, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
4.28
Last Year’s EPS
4.02
Same Quarter Last Year
Based on 13 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 30, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed solid financial and operational performance in Q1 — strong revenue, EBITDA, cash generation, USPI M&A activity, and demonstrated productivity/AI gains — while acknowledging notable near-term headwinds from exchange enrollment declines, lower respiratory volumes, payer disputes and some market-specific Medicaid softness. Management beat expectations for the quarter, maintained financial discipline (deleveraging and share repurchases), and reaffirmed full-year guidance while signaling they will monitor exchange effectuation and regulatory developments. Overall, positive operational momentum and financial strength outweighed the headwinds described.
Company Guidance
Management reaffirmed full‑year 2026 guidance and said it will not update the outlook now despite Q1 outperformance, noting normalized 2026 adjusted EBITDA is expected to grow about 10% at the midpoint after excluding non‑recurring 2025 items and the premium tax credit expiration headwind; they expect Q2 consolidated adjusted EBITDA to be 24–25% of full‑year consolidated adjusted EBITDA at the midpoint (USPI also 24–25% of its full‑year EBITDA), reminded investors that Q1 represented ~22% of USPI’s full‑year EBITDA and 27.5% of Hospital full‑year EBITDA, and reaffirmed adjusted free cash flow after NCI of $1.6–$1.83 billion (which includes ~ $150 million of Conifer‑related tax payments; excluding that tax payment yields a midpoint of about $1.865 billion); capital priorities include a $250 million annual USPI M&A target (already invested $125 million in Q1 for seven ASC acquisitions), continued share repurchases (1.35 million shares for $318 million in Q1), potential debt retirement/refinancing, and the company cites $2.97 billion cash on hand, no draws on the credit facility, leverage of 2.24x EBITDA (2.83x EBITDA less NCI) and no significant maturities until late 2027.
Strong Top-Line and Profitability
Reported Q1 2026 net operating revenues of $5.4 billion and consolidated adjusted EBITDA of $1.162 billion, yielding an adjusted EBITDA margin of 21.6%.
USPI Outperformance and Growth
USPI delivered adjusted EBITDA of $484 million (6% YoY growth) with a 36.7% margin. Same-facility system-wide revenues rose 5.3%, net revenue per case increased 5.6%, and same-facility volumes were essentially stable (down 0.3%).
Hospital Segment Resilience
Hospital segment adjusted EBITDA of $678 million (16.7% margin), representing 27.5% of full-year adjusted EBITDA guidance; same-hospital inpatient adjusted admissions increased 0.6% YoY despite headwinds.
Strong Free Cash Flow and Liquidity
Generated $978 million of adjusted free cash flow in Q1, ended the quarter with $2.97 billion cash on hand, no borrowings on the revolver, and no significant debt maturities until late 2027.
Capital Return to Shareholders
Repurchased 1.35 million shares for $318 million in Q1 and signaled continued share repurchases given current valuations.
Active M&A and Capital Deployment for USPI
Invested $125 million in Q1 to acquire 7 ASCs and commenced patient care at 3 de novo centers (about half of the targeted full-year USPI M&A spend of $250 million), with a robust pipeline of potential assets.
Operational and Technology Productivity Gains
Execution of expense initiatives and technology/AI investments improved productivity and throughput—Conifer analytics productivity reportedly doubled or more; pilots include EMR integrations, ambient scribe, automated discharge summaries and autonomous professional fee coding.
Deleveraging and Financial Discipline
Reported leverage of 2.24x EBITDA (2.83x EBITDA less NCI), reaffirmed full-year guidance and stated normalized adjusted EBITDA growth expectation of ~10% at midpoint (excluding non-recurring items and premium tax credit expiration).

Tenet Healthcare (THC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

THC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 16, 2026
2026 (Q2)
4.28 / -
4.02
Apr 30, 2026
2026 (Q1)
4.17 / 4.82
4.3610.55% (+0.46)
Feb 11, 2026
2025 (Q4)
4.07 / 4.70
3.4436.63% (+1.26)
Oct 28, 2025
2025 (Q3)
3.34 / 3.70
2.9326.28% (+0.77)
Jul 22, 2025
2025 (Q2)
2.88 / 4.02
2.3174.03% (+1.71)
Apr 29, 2025
2025 (Q1)
3.12 / 4.36
3.2235.40% (+1.14)
Feb 12, 2025
2024 (Q4)
2.95 / 3.44
2.6828.36% (+0.76)
Oct 29, 2024
2024 (Q3)
2.37 / 2.93
1.44103.47% (+1.49)
Jul 24, 2024
2024 (Q2)
1.91 / 2.31
1.4460.42% (+0.87)
Apr 30, 2024
2024 (Q1)
1.45 / 3.22
1.42126.76% (+1.80)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

THC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 30, 2026
$180.10$177.12-1.65%
Feb 11, 2026
$193.04$226.35+17.26%
Oct 28, 2025
$216.17$204.62-5.34%
Jul 22, 2025
$174.65$155.97-10.70%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Tenet Healthcare (THC) report earnings?
Tenet Healthcare (THC) is schdueled to report earning on Jul 16, 2026, After Close (Confirmed).
    What is Tenet Healthcare (THC) earnings time?
    Tenet Healthcare (THC) earnings time is at Jul 16, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is THC EPS forecast?
          THC EPS forecast for the fiscal quarter 2026 (Q2) is 4.28.